Fourpath Capital Management’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-1
Closed -$29 493
2024
Q3
$29 Buy
+1
New +$29 ﹤0.01% 772